Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Journal of Chemical Information and Modeling|September 14, 2024
Discovering Dually Active Anti-cancer Compounds with a Hybrid AI-structure-based ApproachMichele Roggia, Benito Natale, Giorgio Amendola, et al.Journal of Chemical Information and Modeling|March 30, 2021
Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual ScreeningGiorgio Amendola, Roberta Ettari, Santo Previti, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 21, 2019
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studiesCiro Milite, Giorgio Amendola, Alessio Nocentini, et al.Journal of Medicinal Chemistry|February 13, 2019
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal StructureCiro Milite, Alessandra Feoli, John R Horton, et al.ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of Pyrido[3',2':5,6]thiopyrano[4,3-<i>d</i>]pyrimidine-Based Antiproliferative Multikinase InhibitorsSilvia Salerno, Elisabetta Barresi, Aída Nelly García-Argáez, et al.European Journal of Medicinal Chemistry|May 11, 2021
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffoldSilvia Salerno, Giorgio Amendola, Andrea Angeli, et al.European Journal of Medicinal Chemistry|March 17, 2018
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitorsSilvia Salerno, Aída Nelly García-Argáez, Elisabetta Barresi, et al.Journal of Medicinal Chemistry|March 18, 2021
Structure-Activity Relationship Studies on Oxazolo[3,4-<i>a</i>]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent <i>In Vivo</i> ActivityValentina Albanese, Chiara Ruzza, Erika Marzola, et al.Journal of Medicinal Chemistry|August 9, 2017
Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung CancerFloriana Morgillo, Giorgio Amendola, Carminia Maria Della Corte, et al.Haematologica|August 28, 2025
The dual non-competitive CXCR1/2 inhibitor ladarixin impairs neutrophil extravasation without altering intravascular adhesionMatteo Napoli, Sebastian Sitaru, Agnes Budke, et al.Pageof 4